Dongbao Bio-Tech released its first-quarter performance, with a net profit attributable to the parent company of 19.0448 million yuan, a year-on-year decrease of 26.64%
I'm LongbridgeAI, I can summarize articles.Dongbao Bio-Tech released its Q1 2025 performance report, with operating revenue of 188 million yuan, a year-on-year decrease of 22.23%; net profit attributable to the parent company of 19.0448 million yuan, a year-on-year decrease of 26.64%; net profit excluding non-recurring gains and losses of 17.7617 million yuan, a year-on-year decrease of 24.81%; basic earnings per share of 0.0323 yuan/share
According to the Zhitong Finance APP, Dongbao Bio-Tech (300239.SZ) released its first quarter report for 2025. The company's operating revenue for the first quarter of 2025 was 188 million yuan, a year-on-year decrease of 22.23%; the net profit attributable to shareholders of the listed company was 19.0448 million yuan, a year-on-year decrease of 26.64%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 17.7617 million yuan, a year-on-year decrease of 24.81%; the basic earnings per share was 0.0323 yuan/share